Ann: First Commercial Sale of APAS Independence, page-61

First 61 Last

Share
Profile

Follow
manuva13

69 Posts.

2

27/08/18

19:07

Post #: 35215109
Share

Originally posted by Callahan70 ↑

I have been bearish in previous posts regarding LBT and still believe that there will be an upside to this company.
The first sale was expected and is a positive, but it has not been enough to change investor sentiment at this point of time. Time lines haven’t been met and all promised milestones have yet to be delivered. I understand the frustration of some posters.
Humans are pretty basic, stimulus and response.
If you were fortunate a few months ago to purchase a million shares at 10 cents and under your sentiment will be better than a longer term investor who has a million shares at .50 cents. Some investors may have taken short term profits, overs may need cash. Some investors may be experiencing investor fatigue with the LBT story and decided to get out.
I believe that this has come into play with this company.
Investor sentiment will improve further when further positive announcements are made to the market. They don’t all need to bee to be price sensitive, they do need to be factual and reflect the work that is going on.
The announcement that a further Australian laboratory was trialling the APAS machine was a positive one. In my mind this is a potential sale. Unfortunately it was included in the Wound Vu announcement. I would have liked to see this as an announcement in its own right. I can cite other announcements which may have mixed messages affecting investor sentiment.
Further short term announcements that may improve sentiment…
Submission of 510k supplement, opening up the US market
Completion of the MRSA module.
CE approval
Announcement of the European distributor.
Potential sales to a German laboratory
Be under no illusion, this is a speculative stock. If milestones are achieved in a timely manner and further sales are made there will be an upside by years end. If not then the result will be self evident. That's how speculation works....
(Disclosure held LBT since 2015, average price .15.)

Expand

A nice summary for the new holders wondering why they aren't riding a price surge mate.

I would add: It's simple. The market (and serious investors) are now wise to this stock. LBT have over promised and under delivered.

Selling a unit to the mob you gave it to to play with 6 months ago is hardly a marketing and sales coupe. Hence no price spike.

It will be YEARS before this company turns a profit that piques the interest of the wider market, so as Callahan said: This is a spec stock. Pop it in the bottom drawer for now.

LBT Price at posting: 12.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 27 more messages in this thread...

First 61 Last

Add LBT (ASX) to my watchlist

(20min delay)
Last 1.7¢		Change -0.001(5.56%)		Mkt cap ! $23.13M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.7¢	$13.20K	747.0K

Buyers (Bids)

No.	Vol.	Price($)
4	776749	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	238095	1

View Market Depth

No.	Vol.	Price($)
1	2173	0.082
1	888	0.076
1	28682	0.070
1	5000	0.065
1	100000	0.062

Price($)	Vol.	No.
0.083	32748	1
0.084	58888	1
0.087	28000	1
0.089	50000	1
0.090	89000	2

Last trade - 16.10pm 26/11/2024 (20 minute delay)

LBT (ASX) Chart

Day chart unavailable

Ann: First Commercial Sale of APAS Independence, page-61

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Buyers (Bids)

Sellers (Offers)